Free Trial

This company has been marked as potentially delisted and may not be actively trading.

FS Development (FSDC) Competitors

FS Development logo

FSDC vs. GMTX, CALT, ZYME, CMRX, CDMO, MENS, SBTX, MBX, RVNC, and CKPT

Should you be buying FS Development stock or one of its competitors? The main competitors of FS Development include Gemini Therapeutics (GMTX), Calliditas Therapeutics AB (publ) (CALT), Zymeworks (ZYME), Chimerix (CMRX), Avid Bioservices (CDMO), Jyong Biotech (MENS), Silverback Therapeutics (SBTX), MBX Biosciences (MBX), Revance Therapeutics (RVNC), and Checkpoint Therapeutics (CKPT).

FS Development vs. Its Competitors

FS Development (NASDAQ:FSDC) and Gemini Therapeutics (NASDAQ:GMTX) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

In the previous week, FS Development's average media sentiment score of 0.00 equaled Gemini Therapeutics'average media sentiment score.

Company Overall Sentiment
FS Development Neutral
Gemini Therapeutics Neutral

89.8% of FS Development shares are held by institutional investors. Comparatively, 75.4% of Gemini Therapeutics shares are held by institutional investors. 12.9% of Gemini Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

FS Development's return on equity of 0.00% beat Gemini Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
FS DevelopmentN/A N/A N/A
Gemini Therapeutics N/A -38.78%-35.88%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FS DevelopmentN/AN/AN/AN/AN/A
Gemini TherapeuticsN/AN/A-$71.87M-$1.00-54.75

Summary

FS Development beats Gemini Therapeutics on 3 of the 4 factors compared between the two stocks.

Get FS Development News Delivered to You Automatically

Sign up to receive the latest news and ratings for FSDC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FSDC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FSDC vs. The Competition

MetricFS DevelopmentPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$685.25M$784.68M$5.45B$8.93B
Dividend YieldN/A4.84%5.22%4.01%
P/E RatioN/A1.3027.2420.06
Price / SalesN/A230.50426.15116.88
Price / CashN/A23.4426.2128.59
Price / BookN/A6.237.925.55
Net IncomeN/A-$27.94M$3.17B$248.56M

FS Development Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FSDC
FS Development
N/A$54.75
+3.0%
N/A+17.4%$685.25MN/A0.00N/A
GMTX
Gemini Therapeutics
N/A$51.13
-3.5%
N/A+17.4%$2.22BN/A-51.1330
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180
ZYME
Zymeworks
2.0528 of 5 stars
$12.89
+3.9%
$21.00
+62.9%
+44.5%$896.85M$93.38M-8.59460
CMRX
Chimerix
0.6253 of 5 stars
$8.54
flat
$8.53
-0.1%
N/A$801.09M$212K-9.0990
CDMO
Avid Bioservices
0.6863 of 5 stars
$12.50
+0.1%
$12.25
-2.0%
+68.4%$799.18M$139.91M-5.23320High Trading Volume
MENS
Jyong Biotech
N/A$9.62
+13.4%
N/AN/A$731.41MN/A0.0031High Trading Volume
SBTX
Silverback Therapeutics
N/A$16.09
-7.8%
N/A+81.5%$580.17MN/A-6.6583High Trading Volume
MBX
MBX Biosciences
3.0678 of 5 stars
$12.33
+6.2%
$37.50
+204.1%
N/A$412.12MN/A0.0036
RVNC
Revance Therapeutics
2.7344 of 5 stars
$3.65
flat
$8.45
+131.5%
N/A$381.02M$234.04M-1.89500
CKPT
Checkpoint Therapeutics
0.4161 of 5 stars
$4.26
flat
$4.33
+1.7%
N/A$370.71M$41K-2.3210

Related Companies and Tools


This page (NASDAQ:FSDC) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners